Risk factors of frequent relapses of steroid-sensitive nephrotic syndrome in children
https://doi.org/10.21508/1027-4065-2014-59-6-80-84
Abstract
Objective: to identify risk factors of frequent relapses nephrotic syndrome in children to choose an optimal treatment policy. Materials and methods. Sixty-six case histories of children with steroid-sensitive nephrotic syndrome were retrospectively analyzed. We investigated relationship between frequency of relapses and clinical manifestations of the disease, namely: gender; age; duration of steroid therapy; time to achieve remission during steroid therapy; time to develop the first relapse of nephrotic syndrome. Results. The age at the onset of nephrotic syndrome younger than 2 years; therapy with daily oral prednisolone (2 ing/kg/day) less than 4 weeks; the total duration of steroid therapy at the onset of disease less than 3 months; the time to achieve remission after initiation of steroid therapy more than 10 days and the time to develop the first relapse less than 5 months after manifestation of nephrotic syndrome are the risk factors of the frequently relapsing disease. Conclusion. The found risk factors of frequent relapses of nephrotic syndrome in children proves the need for adequate steroid therapy in the onset of disease and indication for appointment steroid-sparing agents at the early date to prevent side effects of prednisolone therapy.
About the Authors
V. A. ObukhovaRussian Federation
V. V. Dlin
Russian Federation
References
1. Niaudet Р., Воуег О. Idiopathic Nephrotic Syndrome in Children: Clinical aspects. In: E.D. Avner, W.E. Harmon, P.Niaudet, N. Yoshikawa (eds). Pediatric Nephrology, 6th ed. Berlin Heidelberg: Springer-Verlag 2009; 667—702.
2. Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Groop (2012) KDIGO Clinical Practice Guidelines for Glomerulonephritis. Kidney Int Suppl2012; 2: 163-171.
3. Lombel R.M., Gipson D.S, Hodson E.M. Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO. PediatrNephrol2013; 28: 415-426.
4. Andersen R.F., ThraneN., NoergaardK. etal. Early age at debut is a predictor of steroid-dependent and frequent relapsing nephrotic syndrome. Pediat Nephrol 2010; 25: 1299—1304.
5. Hodson E.M, Knight J.F, Willis N.Setal.Cotfico&temid therapy for nephrotic syndrome in children. Cochrane Database Syst Rev 2005; CD001533.
6. The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of
7. Kidney Disease in Children. J Pediat 1981; 98: 561—564.
8. Nakanishi K, Iijima K., Ishikura K. et al. Two-year outcome of the ISKDC regimen and frequent-relapsing risk in children with idiopathic nephrotic syndrome. Clin J Am Soc Nephrol
9. ; 8:787-796.
10. SureshkumarR, Hodson E., Willis N. etal. Predictors of remission and relapse in idiopathic nephrotic syndrome: a prospective cohort study. Pediat Nephrol 2010; 25:1299—1304.
11. Noer M.S. Predictors of relapse in steroid-sensitive nephrotic syndrome. Southeast Asian J Trop Med Public Health 2005; 36: 1313-1320.
Review
For citations:
Obukhova V.A., Dlin V.V. Risk factors of frequent relapses of steroid-sensitive nephrotic syndrome in children. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2014;59(6):79-83. (In Russ.) https://doi.org/10.21508/1027-4065-2014-59-6-80-84